Look for:

Our offer for

ERSTE STOCK BIOTEC VT


Biotechnology stocks with a focus on the US market

ISIN:
AT0000A0XYP0

2024/04/15
NAV
12,843.8100
Difference -1.40% (-182.95)

General attributes

Fund typeEquity Funds
Investment companyErste Asset Management GmbH
CurrencyCZK
TypeVT
Begin of subscription period-
Inception2000/04/17
Licenced inAT,CZ
Duration of fundopen end
Total assets233,227,566.80 EUR
Fiscal year03/15 - 03/14
Initial charge3.00%
Management fee1.80%
Ongoing charges2.07%
Minimum investmentAccording to offer
Account number-
Recommended holding periodAt least 6 years
Investor experience-
Investor tolerance5 (scale 1-7)
Disclosure RegulationArticle 8

 
Initial charge represents a % of the value of the current fund share unit price and is charged once upon making the investment. Management Fee and Ongoing Charges represent costs paid from the assets of the mutual fund on an annual basis (per annum).



Fund PDF download

ProspectusPDF Download
Key Information Document (KID)PDF Download
Sustainability-related disclosuresPDF Download
CZ DisclaimerPDF Download
CZ FlyerPDF Download
Target market information PDF Download

Fund annual reports

Annual Reports2023/03/14PDF Download
Scale: ABS REL


The chart shows the current fund share unit price (NAV) of the nominal value of an investment company proclaimed on that working day. Performances under 12 month have only little informative value.  Information about previous performance does not guarantee future performance.
Source: Česká spořitelna, a. s.
Advantages Details you should be aware of
Broadly diversified investment in biotechnology companies with little capital investment. Active stock selection based on fundamental criteria. Opportunities for capital appreciation. The fund is suitable as an addition to an existing equity portfolio and is intended for long-term capital appreciation. The price of the fund can fluctuate considerably (high volatility). Due to the investment in foreign currencies the net asset value in Euro can fluctuate due to changes in the exchange rate. Capital loss is possible. Risks that may be significant for the fund are in particular: credit and counterparty risk, liquidity risk, custody risk, derivative risk and operational risk. Comprehensive information on the risks of the fund can be found in the prospectus or the information for investors pursuant to § 21 AIFMG, section II, "Risk information".

Secondary market


THE TARGET MARKET OF THIS INVESTMENT PRODUCT CAN BE FOUND IN FUND PDF DOWNLOAD. PLEASE SEE THIS DOCUMENT.
-------------------------------------------------------------

Purchase of share certificates
Investing in the open-end mutual funds is very easy. If you have already invested with Česká spořitelna, simply remit the invested amount to the collection account number of the selected fund and indicate your MUIN (number of your investment account) as the variable symbol. A comfortable method of investing is represented by GEORGE Internetbanking.

Sale of share certificates

To sell certificates visit any branch of Česká spořitelna or use the GEORGE Internetbanking services.

For new clients

If you have not invested with Česká spořitelna, contact your personal consultant or visit any branch of Česká spořitelna, where we will be happy to answer your questions and help you choose the best investment solution. You just have to make one visit to the Česká spořitelna branch and then you may make investments without any further visits.

 
ČS list of charges for mutual funds unit trading



Risk notes according to 2011 Austrian Investment Fund Act

Unless explicitly noted otherwise, performance figures for periods of less than ten years always start from the launch of the fund. Performance figures for periods of less than 12 months in particular are not indicative of a fund’s development due to their short-term nature.
ERSTE STOCK BIOTEC may exhibit increased volatility due to the composition of its portfolio: i.e. the unit value can be subject to significant fluctuations both upwards and downwards within short periods of time.


Disclaimer

The full names of the open-ended mutual funds and complete product information are provided in the statutes (prospectuses) of the funds. The information stated herein is of the nature of a promotional message. The information stated in this message is not an investment recommendation or investment advice since it does not take into account the specific situation of specific investors. The value of the financial instruments may rise and fall, while there is no guarantee of a return on the originally invested amount. Past performance is no guarantee of the same performance in a future period. A visitor to this website may be outside the target market of the financial instruments stated herein. We recommend that you consult your specific investment plan with an expert advisor who will verify that the planned investment will be commensurate with your knowledge and experience, that it will be in accordance with your needs, characteristics and goals, financial circumstances or relation to risk, and will familiarise you with all possible risks of a specific investment opportunity.

Performance goal and investment strategy

The ERSTE STOCK BIOTEC invests primarily in companies in the developed markets from the field of biotechnology. The fund's investment process is based on fundamental business analysis. The majority of companies in this area can be found in the United States. As a result, Pacific and European equities tend to play a subordinated role in the fund. A hedge against foreign currency risks is generally not provided, but is possible.

Performance (2024/03/28)

Period YTD
6m
1Y
(% p a)
3Y
(% p a)
5Y
(% p a)
10Y
(% p a)
since inc.
(% p a)
Perf 4.99 - 16.87 -0.69 0.65 6.09 10.17

Annual performance in % (2024/03/28)

Period 2019 2020 2021 2022 2023
Perf 32.21 14.45 7.89 -4.73 3.72

 
The stated performance represents the net performance including costs paid from the mutual fund's assets. Entrance fees are not included.

Statistical figures (2024/03/28)

Sharpe Ratio-
Volatility in %16.38

Performance Calculator

Try to calculate the historical performance of the fund with our calculator.

Minimum & maximum performance in % p.a. (2024/03/28)

1Y
117.38
 
-51.90
3Y
52.56
 
-22.95
5Y
42.14
 
-9.64
10Y
21.55
 
-4.24

Disclaimer

The full names of the open-ended mutual funds and complete product information are provided in the statutes (prospectuses) of the funds. The information stated herein is of the nature of a promotional message. The information stated in this message is not an investment recommendation or investment advice since it does not take into account the specific situation of specific investors. The value of the financial instruments may rise and fall, while there is no guarantee of a return on the originally invested amount. Past performance is no guarantee of the same performance in a future period. A visitor to this website may be outside the target market of the financial instruments stated herein. We recommend that you consult your specific investment plan with an expert advisor who will verify that the planned investment will be commensurate with your knowledge and experience, that it will be in accordance with your needs, characteristics and goals, financial circumstances or relation to risk, and will familiarise you with all possible risks of a specific investment opportunity.

Top holdings (2024/03/28)

ISINNameCurrency%FA
-REGENERON PHARMAC.DL-,001-9.37
-ASTRAZENECA DL-,25 SP.ADR-7.86
-VERTEX PHARMAC. DL-,01-7.73
-GILEAD SCIENCES DL-,001-7.50
-BIOGEN INC. DL -,0005-5.13
-AMGEN INC. DL-,0001-4.65
-BIOMARIN PHAR. DL-,001-2.99
-ARGENS SE SP.ADR/1 -,10-2.65
-MADRIGAL PHARMAC. DL-,01-2.50
-SAREPTA THERAP. DL-,0001-2.14

Holdings by country (2024/03/28)

85.30 %United States of America
8.50 %United Kingdom
2.92 %Netherlands
1.09 %Denmark

Percentage holdings by sector (2024/03/28)

83.63 %Biotechnology
12.83 %Pharmaceuticals
2.96 %Life Sciences Tools & Services
0.59 %Health Care Services

Holdings by currency (2024/03/28)

103.20 %USD
 
-3.20 %EUR



Disclaimer

The full names of the open-ended mutual funds and complete product information are provided in the statutes (prospectuses) of the funds. The information stated herein is of the nature of a promotional message. The information stated in this message is not an investment recommendation or investment advice since it does not take into account the specific situation of specific investors. The value of the financial instruments may rise and fall, while there is no guarantee of a return on the originally invested amount. Past performance is no guarantee of the same performance in a future period. A visitor to this website may be outside the target market of the financial instruments stated herein. We recommend that you consult your specific investment plan with an expert advisor who will verify that the planned investment will be commensurate with your knowledge and experience, that it will be in accordance with your needs, characteristics and goals, financial circumstances or relation to risk, and will familiarise you with all possible risks of a specific investment opportunity.

Know-How

 
In our know-how area you can find all relevant details on the different types of bonds. The tutorial gives you selected information about the functionality of bonds and assists you in making your investment decision. In our glossary we explain the most important keywords and within the FAQ section you can find answers to the most common questions concerning this topic.

Find a branch...

Buy securities directly in a branch of Česká spořitelna.

>

Trade via George…

Enjoy the opportunity to trade selected securities online via George, the new banking.

>

Fund chart analyzer

Compare the historical performance of mutual funds.

Performance Calculator

Try to calculate the historical performance of the fund with our calculator.

Performance overview table

Performance of mutual funds for various time periods with weekly updates.

Contact

 
Do you have any further questions which are not covered in our know-how area? Please ask directly our product specialists via our contact form.




Decline
Accept

We use cookies and web analysis software to give you the best possible experience on our website. If you consent, these tools will be used. Please read more information here

INFORMATION FOR PRIVATE CLIENTS / CONSUMERS

Any information, material and services regarding financial instruments and securities provided by Česká spořitelna/Erste Group/ or any of its affiliates (collectively “Erste Group“) on this and any linked website hereafter (jointly the “Websites“) shall be exclusively to investors who are not subject to any legal sale or purchase restrictions.

By agreeing to this hereto, the visitor entering this Websites confirms that has read, understood and accepted this Information and the Disclaimer